nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—ABCB1—Naltrexone—alcohol dependence	0.0202	0.382	CbGbCtD
Bosutinib—Viral upper respiratory tract infection—Citalopram—alcohol dependence	0.0139	0.0496	CcSEcCtD
Bosutinib—ABCB1—Citalopram—alcohol dependence	0.0134	0.253	CbGbCtD
Bosutinib—CYP3A4—Disulfiram—alcohol dependence	0.0112	0.213	CbGbCtD
Bosutinib—Abdominal pain lower—Naltrexone—alcohol dependence	0.00931	0.0333	CcSEcCtD
Bosutinib—CYP3A4—Citalopram—alcohol dependence	0.008	0.152	CbGbCtD
Bosutinib—Rash papular—Naltrexone—alcohol dependence	0.00795	0.0285	CcSEcCtD
Bosutinib—Pancreatitis acute—Naltrexone—alcohol dependence	0.00642	0.023	CcSEcCtD
Bosutinib—Pulmonary hypertension—Citalopram—alcohol dependence	0.00504	0.018	CcSEcCtD
Bosutinib—Hepatotoxicity—Naltrexone—alcohol dependence	0.00384	0.0137	CcSEcCtD
Bosutinib—Abdominal discomfort—Disulfiram—alcohol dependence	0.00382	0.0137	CcSEcCtD
Bosutinib—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.0036	0.0129	CcSEcCtD
Bosutinib—Chest discomfort—Naltrexone—alcohol dependence	0.00335	0.012	CcSEcCtD
Bosutinib—Hepatitis—Disulfiram—alcohol dependence	0.00319	0.0114	CcSEcCtD
Bosutinib—Respiratory tract infection—Citalopram—alcohol dependence	0.00299	0.0107	CcSEcCtD
Bosutinib—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00292	0.0105	CcSEcCtD
Bosutinib—Rash maculo-papular—Acamprosate—alcohol dependence	0.00285	0.0102	CcSEcCtD
Bosutinib—Renal failure acute—Acamprosate—alcohol dependence	0.00246	0.00881	CcSEcCtD
Bosutinib—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00228	0.00817	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00227	0.00813	CcSEcCtD
Bosutinib—Acne—Citalopram—alcohol dependence	0.00223	0.00798	CcSEcCtD
Bosutinib—Face oedema—Acamprosate—alcohol dependence	0.00219	0.00785	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00215	0.0077	CcSEcCtD
Bosutinib—Blood creatinine increased—Acamprosate—alcohol dependence	0.00213	0.00762	CcSEcCtD
Bosutinib—Chest discomfort—Citalopram—alcohol dependence	0.00212	0.00759	CcSEcCtD
Bosutinib—Face oedema—Naltrexone—alcohol dependence	0.00208	0.00743	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00205	0.00733	CcSEcCtD
Bosutinib—Gastritis—Acamprosate—alcohol dependence	0.00201	0.0072	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.002	0.00717	CcSEcCtD
Bosutinib—Dehydration—Naltrexone—alcohol dependence	0.002	0.00716	CcSEcCtD
Bosutinib—Blood bilirubin increased—Citalopram—alcohol dependence	0.00198	0.0071	CcSEcCtD
Bosutinib—Influenza—Acamprosate—alcohol dependence	0.00196	0.00703	CcSEcCtD
Bosutinib—Abdominal pain upper—Naltrexone—alcohol dependence	0.00196	0.00703	CcSEcCtD
Bosutinib—Fatigue—Disulfiram—alcohol dependence	0.00195	0.007	CcSEcCtD
Bosutinib—Pain—Disulfiram—alcohol dependence	0.00194	0.00694	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00194	0.00693	CcSEcCtD
Bosutinib—Nasopharyngitis—Naltrexone—alcohol dependence	0.00192	0.00688	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.0019	0.00679	CcSEcCtD
Bosutinib—Bronchitis—Acamprosate—alcohol dependence	0.00189	0.00676	CcSEcCtD
Bosutinib—Influenza—Naltrexone—alcohol dependence	0.00186	0.00665	CcSEcCtD
Bosutinib—Bronchitis—Naltrexone—alcohol dependence	0.00179	0.0064	CcSEcCtD
Bosutinib—Fluid retention—Citalopram—alcohol dependence	0.00178	0.00638	CcSEcCtD
Bosutinib—Abdominal discomfort—Naltrexone—alcohol dependence	0.00178	0.00638	CcSEcCtD
Bosutinib—Pneumonia—Acamprosate—alcohol dependence	0.00176	0.00631	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00173	0.00618	CcSEcCtD
Bosutinib—Rash maculo-papular—Citalopram—alcohol dependence	0.00171	0.00611	CcSEcCtD
Bosutinib—Pneumonia—Naltrexone—alcohol dependence	0.00167	0.00597	CcSEcCtD
Bosutinib—Infestation NOS—Naltrexone—alcohol dependence	0.00166	0.00593	CcSEcCtD
Bosutinib—Infestation—Naltrexone—alcohol dependence	0.00166	0.00593	CcSEcCtD
Bosutinib—Asthenia—Disulfiram—alcohol dependence	0.00163	0.00582	CcSEcCtD
Bosutinib—Hepatitis—Acamprosate—alcohol dependence	0.00157	0.00563	CcSEcCtD
Bosutinib—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00157	0.00561	CcSEcCtD
Bosutinib—Oedema peripheral—Acamprosate—alcohol dependence	0.00155	0.00554	CcSEcCtD
Bosutinib—Dizziness—Disulfiram—alcohol dependence	0.0015	0.00537	CcSEcCtD
Bosutinib—Hepatitis—Naltrexone—alcohol dependence	0.00149	0.00532	CcSEcCtD
Bosutinib—Renal failure acute—Citalopram—alcohol dependence	0.00148	0.00528	CcSEcCtD
Bosutinib—Tinnitus—Acamprosate—alcohol dependence	0.00147	0.00525	CcSEcCtD
Bosutinib—Connective tissue disorder—Naltrexone—alcohol dependence	0.00146	0.00523	CcSEcCtD
Bosutinib—Rash—Disulfiram—alcohol dependence	0.00143	0.00512	CcSEcCtD
Bosutinib—Headache—Disulfiram—alcohol dependence	0.00142	0.00508	CcSEcCtD
Bosutinib—Immune system disorder—Acamprosate—alcohol dependence	0.00142	0.00508	CcSEcCtD
Bosutinib—Tinnitus—Naltrexone—alcohol dependence	0.00139	0.00496	CcSEcCtD
Bosutinib—Cardiac disorder—Naltrexone—alcohol dependence	0.00138	0.00494	CcSEcCtD
Bosutinib—Malnutrition—Acamprosate—alcohol dependence	0.00137	0.0049	CcSEcCtD
Bosutinib—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00136	0.00488	CcSEcCtD
Bosutinib—Immune system disorder—Naltrexone—alcohol dependence	0.00134	0.00481	CcSEcCtD
Bosutinib—Mediastinal disorder—Naltrexone—alcohol dependence	0.00134	0.0048	CcSEcCtD
Bosutinib—Dysgeusia—Acamprosate—alcohol dependence	0.00134	0.0048	CcSEcCtD
Bosutinib—Back pain—Acamprosate—alcohol dependence	0.00132	0.00474	CcSEcCtD
Bosutinib—Face oedema—Citalopram—alcohol dependence	0.00132	0.00471	CcSEcCtD
Bosutinib—Malnutrition—Naltrexone—alcohol dependence	0.00129	0.00463	CcSEcCtD
Bosutinib—Ill-defined disorder—Acamprosate—alcohol dependence	0.00127	0.00455	CcSEcCtD
Bosutinib—Dysgeusia—Naltrexone—alcohol dependence	0.00127	0.00454	CcSEcCtD
Bosutinib—Dehydration—Citalopram—alcohol dependence	0.00127	0.00454	CcSEcCtD
Bosutinib—Anaemia—Acamprosate—alcohol dependence	0.00126	0.00453	CcSEcCtD
Bosutinib—Back pain—Naltrexone—alcohol dependence	0.00125	0.00448	CcSEcCtD
Bosutinib—Abdominal pain upper—Citalopram—alcohol dependence	0.00124	0.00445	CcSEcCtD
Bosutinib—Malaise—Acamprosate—alcohol dependence	0.00123	0.00442	CcSEcCtD
Bosutinib—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00123	0.00439	CcSEcCtD
Bosutinib—Leukopenia—Acamprosate—alcohol dependence	0.00123	0.00439	CcSEcCtD
Bosutinib—Nasopharyngitis—Citalopram—alcohol dependence	0.00122	0.00436	CcSEcCtD
Bosutinib—Gastritis—Citalopram—alcohol dependence	0.00121	0.00432	CcSEcCtD
Bosutinib—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.0012	0.0043	CcSEcCtD
Bosutinib—Ill-defined disorder—Naltrexone—alcohol dependence	0.0012	0.0043	CcSEcCtD
Bosutinib—Cough—Acamprosate—alcohol dependence	0.00119	0.00427	CcSEcCtD
Bosutinib—Influenza—Citalopram—alcohol dependence	0.00118	0.00421	CcSEcCtD
Bosutinib—Malaise—Naltrexone—alcohol dependence	0.00117	0.00418	CcSEcCtD
Bosutinib—Myalgia—Acamprosate—alcohol dependence	0.00117	0.00417	CcSEcCtD
Bosutinib—Chest pain—Acamprosate—alcohol dependence	0.00117	0.00417	CcSEcCtD
Bosutinib—Arthralgia—Acamprosate—alcohol dependence	0.00117	0.00417	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00116	0.00414	CcSEcCtD
Bosutinib—Discomfort—Acamprosate—alcohol dependence	0.00115	0.00412	CcSEcCtD
Bosutinib—Bronchitis—Citalopram—alcohol dependence	0.00113	0.00405	CcSEcCtD
Bosutinib—Cough—Naltrexone—alcohol dependence	0.00113	0.00404	CcSEcCtD
Bosutinib—Abdominal discomfort—Citalopram—alcohol dependence	0.00113	0.00404	CcSEcCtD
Bosutinib—Pancytopenia—Citalopram—alcohol dependence	0.00112	0.004	CcSEcCtD
Bosutinib—Anaphylactic shock—Acamprosate—alcohol dependence	0.00112	0.004	CcSEcCtD
Bosutinib—Infection—Acamprosate—alcohol dependence	0.00111	0.00397	CcSEcCtD
Bosutinib—Arthralgia—Naltrexone—alcohol dependence	0.0011	0.00395	CcSEcCtD
Bosutinib—Myalgia—Naltrexone—alcohol dependence	0.0011	0.00395	CcSEcCtD
Bosutinib—Chest pain—Naltrexone—alcohol dependence	0.0011	0.00395	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00109	0.00392	CcSEcCtD
Bosutinib—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00109	0.00392	CcSEcCtD
Bosutinib—Thrombocytopenia—Acamprosate—alcohol dependence	0.00109	0.00391	CcSEcCtD
Bosutinib—Discomfort—Naltrexone—alcohol dependence	0.00109	0.0039	CcSEcCtD
Bosutinib—Skin disorder—Acamprosate—alcohol dependence	0.00108	0.00388	CcSEcCtD
Bosutinib—Anaphylactic shock—Naltrexone—alcohol dependence	0.00106	0.00378	CcSEcCtD
Bosutinib—Oedema—Naltrexone—alcohol dependence	0.00106	0.00378	CcSEcCtD
Bosutinib—Pneumonia—Citalopram—alcohol dependence	0.00106	0.00378	CcSEcCtD
Bosutinib—Infection—Naltrexone—alcohol dependence	0.00105	0.00376	CcSEcCtD
Bosutinib—Infestation—Citalopram—alcohol dependence	0.00105	0.00376	CcSEcCtD
Bosutinib—Infestation NOS—Citalopram—alcohol dependence	0.00105	0.00376	CcSEcCtD
Bosutinib—Nervous system disorder—Naltrexone—alcohol dependence	0.00104	0.00371	CcSEcCtD
Bosutinib—Skin disorder—Naltrexone—alcohol dependence	0.00103	0.00367	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00102	0.00364	CcSEcCtD
Bosutinib—Dyspnoea—Acamprosate—alcohol dependence	0.000996	0.00356	CcSEcCtD
Bosutinib—Hepatobiliary disease—Citalopram—alcohol dependence	0.000993	0.00355	CcSEcCtD
Bosutinib—Agranulocytosis—Citalopram—alcohol dependence	0.00098	0.00351	CcSEcCtD
Bosutinib—Decreased appetite—Acamprosate—alcohol dependence	0.000971	0.00348	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000964	0.00345	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000963	0.00345	CcSEcCtD
Bosutinib—Pain—Acamprosate—alcohol dependence	0.000955	0.00342	CcSEcCtD
Bosutinib—Hepatitis—Citalopram—alcohol dependence	0.000942	0.00337	CcSEcCtD
Bosutinib—Dyspnoea—Naltrexone—alcohol dependence	0.000942	0.00337	CcSEcCtD
Bosutinib—Urinary tract disorder—Citalopram—alcohol dependence	0.000931	0.00333	CcSEcCtD
Bosutinib—Oedema peripheral—Citalopram—alcohol dependence	0.000928	0.00332	CcSEcCtD
Bosutinib—Connective tissue disorder—Citalopram—alcohol dependence	0.000926	0.00332	CcSEcCtD
Bosutinib—Urethral disorder—Citalopram—alcohol dependence	0.000924	0.00331	CcSEcCtD
Bosutinib—Feeling abnormal—Acamprosate—alcohol dependence	0.00092	0.00329	CcSEcCtD
Bosutinib—Decreased appetite—Naltrexone—alcohol dependence	0.000919	0.00329	CcSEcCtD
Bosutinib—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000913	0.00327	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000912	0.00327	CcSEcCtD
Bosutinib—Fatigue—Naltrexone—alcohol dependence	0.000911	0.00326	CcSEcCtD
Bosutinib—Pain—Naltrexone—alcohol dependence	0.000904	0.00323	CcSEcCtD
Bosutinib—Erythema multiforme—Citalopram—alcohol dependence	0.000891	0.00319	CcSEcCtD
Bosutinib—Urticaria—Acamprosate—alcohol dependence	0.000887	0.00318	CcSEcCtD
Bosutinib—Abdominal pain—Acamprosate—alcohol dependence	0.000883	0.00316	CcSEcCtD
Bosutinib—Body temperature increased—Acamprosate—alcohol dependence	0.000883	0.00316	CcSEcCtD
Bosutinib—Tinnitus—Citalopram—alcohol dependence	0.000879	0.00315	CcSEcCtD
Bosutinib—Cardiac disorder—Citalopram—alcohol dependence	0.000875	0.00313	CcSEcCtD
Bosutinib—Feeling abnormal—Naltrexone—alcohol dependence	0.000871	0.00312	CcSEcCtD
Bosutinib—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000864	0.00309	CcSEcCtD
Bosutinib—Immune system disorder—Citalopram—alcohol dependence	0.000851	0.00305	CcSEcCtD
Bosutinib—Mediastinal disorder—Citalopram—alcohol dependence	0.000849	0.00304	CcSEcCtD
Bosutinib—Urticaria—Naltrexone—alcohol dependence	0.00084	0.00301	CcSEcCtD
Bosutinib—Abdominal pain—Naltrexone—alcohol dependence	0.000835	0.00299	CcSEcCtD
Bosutinib—Body temperature increased—Naltrexone—alcohol dependence	0.000835	0.00299	CcSEcCtD
Bosutinib—Malnutrition—Citalopram—alcohol dependence	0.00082	0.00294	CcSEcCtD
Bosutinib—Dysgeusia—Citalopram—alcohol dependence	0.000803	0.00288	CcSEcCtD
Bosutinib—Asthenia—Acamprosate—alcohol dependence	0.000801	0.00287	CcSEcCtD
Bosutinib—Back pain—Citalopram—alcohol dependence	0.000794	0.00284	CcSEcCtD
Bosutinib—Pruritus—Acamprosate—alcohol dependence	0.00079	0.00283	CcSEcCtD
Bosutinib—Diarrhoea—Acamprosate—alcohol dependence	0.000764	0.00274	CcSEcCtD
Bosutinib—Ill-defined disorder—Citalopram—alcohol dependence	0.000761	0.00272	CcSEcCtD
Bosutinib—Anaemia—Citalopram—alcohol dependence	0.000758	0.00271	CcSEcCtD
Bosutinib—Asthenia—Naltrexone—alcohol dependence	0.000758	0.00271	CcSEcCtD
Bosutinib—Pruritus—Naltrexone—alcohol dependence	0.000748	0.00268	CcSEcCtD
Bosutinib—Malaise—Citalopram—alcohol dependence	0.00074	0.00265	CcSEcCtD
Bosutinib—Dizziness—Acamprosate—alcohol dependence	0.000739	0.00264	CcSEcCtD
Bosutinib—Leukopenia—Citalopram—alcohol dependence	0.000734	0.00263	CcSEcCtD
Bosutinib—Diarrhoea—Naltrexone—alcohol dependence	0.000723	0.00259	CcSEcCtD
Bosutinib—Cough—Citalopram—alcohol dependence	0.000716	0.00256	CcSEcCtD
Bosutinib—Vomiting—Acamprosate—alcohol dependence	0.00071	0.00254	CcSEcCtD
Bosutinib—Rash—Acamprosate—alcohol dependence	0.000704	0.00252	CcSEcCtD
Bosutinib—Dermatitis—Acamprosate—alcohol dependence	0.000704	0.00252	CcSEcCtD
Bosutinib—Headache—Acamprosate—alcohol dependence	0.0007	0.0025	CcSEcCtD
Bosutinib—Dizziness—Naltrexone—alcohol dependence	0.000699	0.0025	CcSEcCtD
Bosutinib—Arthralgia—Citalopram—alcohol dependence	0.000698	0.0025	CcSEcCtD
Bosutinib—Myalgia—Citalopram—alcohol dependence	0.000698	0.0025	CcSEcCtD
Bosutinib—Chest pain—Citalopram—alcohol dependence	0.000698	0.0025	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000694	0.00248	CcSEcCtD
Bosutinib—Discomfort—Citalopram—alcohol dependence	0.00069	0.00247	CcSEcCtD
Bosutinib—Vomiting—Naltrexone—alcohol dependence	0.000672	0.00241	CcSEcCtD
Bosutinib—Anaphylactic shock—Citalopram—alcohol dependence	0.00067	0.0024	CcSEcCtD
Bosutinib—Oedema—Citalopram—alcohol dependence	0.00067	0.0024	CcSEcCtD
Bosutinib—Rash—Naltrexone—alcohol dependence	0.000666	0.00239	CcSEcCtD
Bosutinib—Dermatitis—Naltrexone—alcohol dependence	0.000666	0.00238	CcSEcCtD
Bosutinib—Infection—Citalopram—alcohol dependence	0.000665	0.00238	CcSEcCtD
Bosutinib—Nausea—Acamprosate—alcohol dependence	0.000663	0.00237	CcSEcCtD
Bosutinib—Headache—Naltrexone—alcohol dependence	0.000662	0.00237	CcSEcCtD
Bosutinib—Nervous system disorder—Citalopram—alcohol dependence	0.000657	0.00235	CcSEcCtD
Bosutinib—Thrombocytopenia—Citalopram—alcohol dependence	0.000656	0.00235	CcSEcCtD
Bosutinib—Skin disorder—Citalopram—alcohol dependence	0.00065	0.00233	CcSEcCtD
Bosutinib—Nausea—Naltrexone—alcohol dependence	0.000628	0.00225	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00061	0.00218	CcSEcCtD
Bosutinib—Dyspnoea—Citalopram—alcohol dependence	0.000597	0.00214	CcSEcCtD
Bosutinib—Decreased appetite—Citalopram—alcohol dependence	0.000582	0.00208	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000578	0.00207	CcSEcCtD
Bosutinib—Fatigue—Citalopram—alcohol dependence	0.000577	0.00207	CcSEcCtD
Bosutinib—Pain—Citalopram—alcohol dependence	0.000573	0.00205	CcSEcCtD
Bosutinib—Feeling abnormal—Citalopram—alcohol dependence	0.000552	0.00198	CcSEcCtD
Bosutinib—Gastrointestinal pain—Citalopram—alcohol dependence	0.000548	0.00196	CcSEcCtD
Bosutinib—Urticaria—Citalopram—alcohol dependence	0.000532	0.0019	CcSEcCtD
Bosutinib—Body temperature increased—Citalopram—alcohol dependence	0.000529	0.00189	CcSEcCtD
Bosutinib—Abdominal pain—Citalopram—alcohol dependence	0.000529	0.00189	CcSEcCtD
Bosutinib—Asthenia—Citalopram—alcohol dependence	0.00048	0.00172	CcSEcCtD
Bosutinib—Pruritus—Citalopram—alcohol dependence	0.000474	0.0017	CcSEcCtD
Bosutinib—Diarrhoea—Citalopram—alcohol dependence	0.000458	0.00164	CcSEcCtD
Bosutinib—Dizziness—Citalopram—alcohol dependence	0.000443	0.00158	CcSEcCtD
Bosutinib—Vomiting—Citalopram—alcohol dependence	0.000426	0.00152	CcSEcCtD
Bosutinib—Rash—Citalopram—alcohol dependence	0.000422	0.00151	CcSEcCtD
Bosutinib—Dermatitis—Citalopram—alcohol dependence	0.000422	0.00151	CcSEcCtD
Bosutinib—Headache—Citalopram—alcohol dependence	0.000419	0.0015	CcSEcCtD
Bosutinib—Nausea—Citalopram—alcohol dependence	0.000398	0.00142	CcSEcCtD
Bosutinib—EGFR—cerebellum—alcohol dependence	0.000322	0.000791	CbGeAlD
Bosutinib—PTK2B—central nervous system—alcohol dependence	0.000322	0.000791	CbGeAlD
Bosutinib—BTK—brain—alcohol dependence	0.000322	0.00079	CbGeAlD
Bosutinib—EPHA4—nervous system—alcohol dependence	0.000321	0.000788	CbGeAlD
Bosutinib—MAP3K2—testis—alcohol dependence	0.000321	0.000787	CbGeAlD
Bosutinib—YES1—digestive system—alcohol dependence	0.000321	0.000787	CbGeAlD
Bosutinib—ERBB3—nervous system—alcohol dependence	0.000318	0.00078	CbGeAlD
Bosutinib—STK10—digestive system—alcohol dependence	0.000318	0.00078	CbGeAlD
Bosutinib—MAP3K7—testis—alcohol dependence	0.000318	0.00078	CbGeAlD
Bosutinib—TNK2—brain—alcohol dependence	0.000318	0.000779	CbGeAlD
Bosutinib—CSNK1E—liver—alcohol dependence	0.000317	0.000778	CbGeAlD
Bosutinib—CSNK1E—central nervous system—alcohol dependence	0.000317	0.000778	CbGeAlD
Bosutinib—MAP2K2—nervous system—alcohol dependence	0.000317	0.000778	CbGeAlD
Bosutinib—ULK3—nervous system—alcohol dependence	0.000317	0.000778	CbGeAlD
Bosutinib—RPS6KB1—endocrine gland—alcohol dependence	0.000317	0.000777	CbGeAlD
Bosutinib—TAOK3—digestive system—alcohol dependence	0.000317	0.000777	CbGeAlD
Bosutinib—PTK2B—cerebellum—alcohol dependence	0.000315	0.000773	CbGeAlD
Bosutinib—FGR—endocrine gland—alcohol dependence	0.000315	0.000773	CbGeAlD
Bosutinib—MAP3K2—nervous system—alcohol dependence	0.000315	0.000772	CbGeAlD
Bosutinib—PTK2—testis—alcohol dependence	0.000314	0.000771	CbGeAlD
Bosutinib—TBK1—testis—alcohol dependence	0.000314	0.000771	CbGeAlD
Bosutinib—AXL—endocrine gland—alcohol dependence	0.000314	0.00077	CbGeAlD
Bosutinib—MAP4K2—brain—alcohol dependence	0.000313	0.000768	CbGeAlD
Bosutinib—SIK1—liver—alcohol dependence	0.000312	0.000766	CbGeAlD
Bosutinib—IRAK4—liver—alcohol dependence	0.000312	0.000766	CbGeAlD
Bosutinib—SIK1—central nervous system—alcohol dependence	0.000312	0.000766	CbGeAlD
Bosutinib—IRAK4—central nervous system—alcohol dependence	0.000312	0.000766	CbGeAlD
Bosutinib—CSNK1E—cerebellum—alcohol dependence	0.00031	0.00076	CbGeAlD
Bosutinib—EPHA4—central nervous system—alcohol dependence	0.000309	0.000758	CbGeAlD
Bosutinib—ERBB4—brain—alcohol dependence	0.000309	0.000758	CbGeAlD
Bosutinib—STK3—brain—alcohol dependence	0.000309	0.000758	CbGeAlD
Bosutinib—SRC—digestive system—alcohol dependence	0.000308	0.000757	CbGeAlD
Bosutinib—PTK2—nervous system—alcohol dependence	0.000308	0.000756	CbGeAlD
Bosutinib—TBK1—nervous system—alcohol dependence	0.000308	0.000756	CbGeAlD
Bosutinib—IRAK1—testis—alcohol dependence	0.000308	0.000756	CbGeAlD
Bosutinib—ERBB3—liver—alcohol dependence	0.000306	0.000751	CbGeAlD
Bosutinib—ERBB3—central nervous system—alcohol dependence	0.000306	0.000751	CbGeAlD
Bosutinib—YES1—blood—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—MAP2K2—liver—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—ULK3—liver—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—MAP2K2—central nervous system—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—ULK3—central nervous system—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—SIK1—cerebellum—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—IRAK4—cerebellum—alcohol dependence	0.000305	0.000749	CbGeAlD
Bosutinib—ROCK1—brain—alcohol dependence	0.000305	0.000748	CbGeAlD
Bosutinib—MAP3K2—liver—alcohol dependence	0.000303	0.000744	CbGeAlD
Bosutinib—MAP3K2—central nervous system—alcohol dependence	0.000303	0.000744	CbGeAlD
Bosutinib—CSF1R—gonad—alcohol dependence	0.000303	0.000743	CbGeAlD
Bosutinib—STK10—blood—alcohol dependence	0.000303	0.000743	CbGeAlD
Bosutinib—RPS6KB1—testis—alcohol dependence	0.000302	0.000741	CbGeAlD
Bosutinib—EPHA4—cerebellum—alcohol dependence	0.000302	0.000741	CbGeAlD
Bosutinib—YES1—midbrain—alcohol dependence	0.000302	0.00074	CbGeAlD
Bosutinib—TAOK3—blood—alcohol dependence	0.000302	0.00074	CbGeAlD
Bosutinib—MAP3K7—liver—alcohol dependence	0.0003	0.000737	CbGeAlD
Bosutinib—FGR—testis—alcohol dependence	0.0003	0.000737	CbGeAlD
Bosutinib—LCK—testis—alcohol dependence	0.0003	0.000737	CbGeAlD
Bosutinib—EPHB4—endocrine gland—alcohol dependence	0.0003	0.000735	CbGeAlD
Bosutinib—AXL—testis—alcohol dependence	0.000299	0.000734	CbGeAlD
Bosutinib—ERBB3—cerebellum—alcohol dependence	0.000299	0.000734	CbGeAlD
Bosutinib—ULK3—cerebellum—alcohol dependence	0.000298	0.000732	CbGeAlD
Bosutinib—MAP2K2—cerebellum—alcohol dependence	0.000298	0.000732	CbGeAlD
Bosutinib—TAOK3—midbrain—alcohol dependence	0.000298	0.000731	CbGeAlD
Bosutinib—PTK2—liver—alcohol dependence	0.000297	0.000729	CbGeAlD
Bosutinib—TBK1—liver—alcohol dependence	0.000297	0.000729	CbGeAlD
Bosutinib—PTK2—central nervous system—alcohol dependence	0.000297	0.000728	CbGeAlD
Bosutinib—TBK1—central nervous system—alcohol dependence	0.000297	0.000728	CbGeAlD
Bosutinib—RPS6KB1—nervous system—alcohol dependence	0.000297	0.000728	CbGeAlD
Bosutinib—MAP3K2—cerebellum—alcohol dependence	0.000296	0.000727	CbGeAlD
Bosutinib—BMPR2—brain—alcohol dependence	0.000296	0.000726	CbGeAlD
Bosutinib—PDGFRB—cardiovascular system—alcohol dependence	0.000296	0.000726	CbGeAlD
Bosutinib—FGR—nervous system—alcohol dependence	0.000295	0.000723	CbGeAlD
Bosutinib—EPHA2—endocrine gland—alcohol dependence	0.000294	0.000721	CbGeAlD
Bosutinib—SRC—blood—alcohol dependence	0.000294	0.000721	CbGeAlD
Bosutinib—EPHB3—brain—alcohol dependence	0.000294	0.000721	CbGeAlD
Bosutinib—STK36—brain—alcohol dependence	0.000294	0.000721	CbGeAlD
Bosutinib—AXL—nervous system—alcohol dependence	0.000294	0.00072	CbGeAlD
Bosutinib—FYN—endocrine gland—alcohol dependence	0.000294	0.00072	CbGeAlD
Bosutinib—MAP3K7—cerebellum—alcohol dependence	0.000293	0.00072	CbGeAlD
Bosutinib—IRAK1—liver—alcohol dependence	0.000291	0.000714	CbGeAlD
Bosutinib—MERTK—brain—alcohol dependence	0.00029	0.000712	CbGeAlD
Bosutinib—PTK2—cerebellum—alcohol dependence	0.00029	0.000712	CbGeAlD
Bosutinib—TBK1—cerebellum—alcohol dependence	0.00029	0.000712	CbGeAlD
Bosutinib—ABL1—adrenal cortex—alcohol dependence	0.000289	0.000709	CbGeAlD
Bosutinib—SLK—testis—alcohol dependence	0.000288	0.000706	CbGeAlD
Bosutinib—PDGFRB—pancreas—alcohol dependence	0.000288	0.000706	CbGeAlD
Bosutinib—MAP3K3—endocrine gland—alcohol dependence	0.000287	0.000704	CbGeAlD
Bosutinib—MAP4K5—endocrine gland—alcohol dependence	0.000287	0.000704	CbGeAlD
Bosutinib—EPHB4—testis—alcohol dependence	0.000286	0.000701	CbGeAlD
Bosutinib—RPS6KB1—liver—alcohol dependence	0.000286	0.000701	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—alcohol dependence	0.000286	0.000701	CbGeAlD
Bosutinib—MAP4K4—brain—alcohol dependence	0.000285	0.000699	CbGeAlD
Bosutinib—IRAK1—cerebellum—alcohol dependence	0.000284	0.000698	CbGeAlD
Bosutinib—FGR—liver—alcohol dependence	0.000284	0.000697	CbGeAlD
Bosutinib—LCK—liver—alcohol dependence	0.000284	0.000697	CbGeAlD
Bosutinib—FGR—central nervous system—alcohol dependence	0.000284	0.000696	CbGeAlD
Bosutinib—BCR—brain—alcohol dependence	0.000283	0.000694	CbGeAlD
Bosutinib—NUAK2—brain—alcohol dependence	0.000283	0.000694	CbGeAlD
Bosutinib—AXL—liver—alcohol dependence	0.000283	0.000694	CbGeAlD
Bosutinib—AXL—central nervous system—alcohol dependence	0.000283	0.000693	CbGeAlD
Bosutinib—MAP3K12—brain—alcohol dependence	0.000281	0.000689	CbGeAlD
Bosutinib—EPHA2—testis—alcohol dependence	0.00028	0.000688	CbGeAlD
Bosutinib—FYN—testis—alcohol dependence	0.00028	0.000687	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—alcohol dependence	0.000279	0.000685	CbGeAlD
Bosutinib—CSF1R—digestive system—alcohol dependence	0.000277	0.000679	CbGeAlD
Bosutinib—AXL—cerebellum—alcohol dependence	0.000276	0.000678	CbGeAlD
Bosutinib—MAP2K1—brain—alcohol dependence	0.000275	0.000675	CbGeAlD
Bosutinib—STK35—brain—alcohol dependence	0.000275	0.000675	CbGeAlD
Bosutinib—EPHA2—nervous system—alcohol dependence	0.000275	0.000675	CbGeAlD
Bosutinib—FYN—nervous system—alcohol dependence	0.000275	0.000674	CbGeAlD
Bosutinib—MAP3K3—testis—alcohol dependence	0.000274	0.000671	CbGeAlD
Bosutinib—MAP4K5—testis—alcohol dependence	0.000274	0.000671	CbGeAlD
Bosutinib—CSK—brain—alcohol dependence	0.000273	0.000671	CbGeAlD
Bosutinib—SLK—liver—alcohol dependence	0.000272	0.000668	CbGeAlD
Bosutinib—CSNK1A1—brain—alcohol dependence	0.000272	0.000667	CbGeAlD
Bosutinib—MAP2K5—blood—alcohol dependence	0.00027	0.000663	CbGeAlD
Bosutinib—EPHB4—liver—alcohol dependence	0.00027	0.000663	CbGeAlD
Bosutinib—CLK1—brain—alcohol dependence	0.00027	0.000662	CbGeAlD
Bosutinib—HCK—brain—alcohol dependence	0.00027	0.000662	CbGeAlD
Bosutinib—PDGFRB—gonad—alcohol dependence	0.000269	0.000659	CbGeAlD
Bosutinib—MAP4K5—nervous system—alcohol dependence	0.000269	0.000659	CbGeAlD
Bosutinib—MAP3K3—nervous system—alcohol dependence	0.000269	0.000659	CbGeAlD
Bosutinib—ABL2—brain—alcohol dependence	0.000268	0.000658	CbGeAlD
Bosutinib—MAP2K5—midbrain—alcohol dependence	0.000267	0.000655	CbGeAlD
Bosutinib—SLK—cerebellum—alcohol dependence	0.000266	0.000652	CbGeAlD
Bosutinib—EPHA2—liver—alcohol dependence	0.000265	0.000651	CbGeAlD
Bosutinib—EPHA2—central nervous system—alcohol dependence	0.000265	0.00065	CbGeAlD
Bosutinib—CAMK2G—brain—alcohol dependence	0.000265	0.00065	CbGeAlD
Bosutinib—BMP2K—brain—alcohol dependence	0.000265	0.00065	CbGeAlD
Bosutinib—YES1—endocrine gland—alcohol dependence	0.000265	0.00065	CbGeAlD
Bosutinib—FYN—liver—alcohol dependence	0.000265	0.000649	CbGeAlD
Bosutinib—FYN—central nervous system—alcohol dependence	0.000265	0.000649	CbGeAlD
Bosutinib—EPHB4—cerebellum—alcohol dependence	0.000264	0.000648	CbGeAlD
Bosutinib—CSF1R—blood—alcohol dependence	0.000264	0.000647	CbGeAlD
Bosutinib—ABL1—cardiovascular system—alcohol dependence	0.000264	0.000647	CbGeAlD
Bosutinib—LRRK2—brain—alcohol dependence	0.000263	0.000644	CbGeAlD
Bosutinib—STK10—endocrine gland—alcohol dependence	0.000263	0.000644	CbGeAlD
Bosutinib—EGFR—brain—alcohol dependence	0.000262	0.000642	CbGeAlD
Bosutinib—TAOK3—endocrine gland—alcohol dependence	0.000262	0.000642	CbGeAlD
Bosutinib—CSF1R—midbrain—alcohol dependence	0.000261	0.000639	CbGeAlD
Bosutinib—MAP3K3—liver—alcohol dependence	0.000259	0.000635	CbGeAlD
Bosutinib—MAP4K5—liver—alcohol dependence	0.000259	0.000635	CbGeAlD
Bosutinib—FYN—cerebellum—alcohol dependence	0.000259	0.000634	CbGeAlD
Bosutinib—MAP3K3—central nervous system—alcohol dependence	0.000259	0.000634	CbGeAlD
Bosutinib—MAP4K5—central nervous system—alcohol dependence	0.000259	0.000634	CbGeAlD
Bosutinib—ABL1—pancreas—alcohol dependence	0.000256	0.000629	CbGeAlD
Bosutinib—PTK2B—brain—alcohol dependence	0.000256	0.000628	CbGeAlD
Bosutinib—SRC—endocrine gland—alcohol dependence	0.000255	0.000625	CbGeAlD
Bosutinib—MAP3K3—cerebellum—alcohol dependence	0.000253	0.00062	CbGeAlD
Bosutinib—MAP4K5—cerebellum—alcohol dependence	0.000253	0.00062	CbGeAlD
Bosutinib—YES1—testis—alcohol dependence	0.000253	0.00062	CbGeAlD
Bosutinib—CSNK1E—brain—alcohol dependence	0.000252	0.000618	CbGeAlD
Bosutinib—STK10—testis—alcohol dependence	0.00025	0.000614	CbGeAlD
Bosutinib—TAOK3—testis—alcohol dependence	0.000249	0.000612	CbGeAlD
Bosutinib—YES1—nervous system—alcohol dependence	0.000248	0.000608	CbGeAlD
Bosutinib—SIK1—brain—alcohol dependence	0.000248	0.000608	CbGeAlD
Bosutinib—IRAK4—brain—alcohol dependence	0.000248	0.000608	CbGeAlD
Bosutinib—STK10—nervous system—alcohol dependence	0.000246	0.000603	CbGeAlD
Bosutinib—PDGFRB—digestive system—alcohol dependence	0.000246	0.000603	CbGeAlD
Bosutinib—EPHA4—brain—alcohol dependence	0.000245	0.000602	CbGeAlD
Bosutinib—TAOK3—nervous system—alcohol dependence	0.000245	0.000601	CbGeAlD
Bosutinib—SRC—testis—alcohol dependence	0.000243	0.000596	CbGeAlD
Bosutinib—ERBB3—brain—alcohol dependence	0.000243	0.000596	CbGeAlD
Bosutinib—MAP2K2—brain—alcohol dependence	0.000242	0.000595	CbGeAlD
Bosutinib—ULK3—brain—alcohol dependence	0.000242	0.000595	CbGeAlD
Bosutinib—MAP3K2—brain—alcohol dependence	0.000241	0.00059	CbGeAlD
Bosutinib—ABL1—gonad—alcohol dependence	0.000239	0.000587	CbGeAlD
Bosutinib—YES1—liver—alcohol dependence	0.000239	0.000586	CbGeAlD
Bosutinib—YES1—central nervous system—alcohol dependence	0.000239	0.000586	CbGeAlD
Bosutinib—SRC—nervous system—alcohol dependence	0.000239	0.000585	CbGeAlD
Bosutinib—MAP3K7—brain—alcohol dependence	0.000238	0.000585	CbGeAlD
Bosutinib—STK10—liver—alcohol dependence	0.000237	0.000581	CbGeAlD
Bosutinib—STK10—central nervous system—alcohol dependence	0.000237	0.00058	CbGeAlD
Bosutinib—TAOK3—liver—alcohol dependence	0.000236	0.000579	CbGeAlD
Bosutinib—TAOK3—central nervous system—alcohol dependence	0.000236	0.000578	CbGeAlD
Bosutinib—PTK2—brain—alcohol dependence	0.000236	0.000578	CbGeAlD
Bosutinib—TBK1—brain—alcohol dependence	0.000236	0.000578	CbGeAlD
Bosutinib—MAP2K5—endocrine gland—alcohol dependence	0.000234	0.000575	CbGeAlD
Bosutinib—PDGFRB—blood—alcohol dependence	0.000234	0.000574	CbGeAlD
Bosutinib—YES1—cerebellum—alcohol dependence	0.000233	0.000573	CbGeAlD
Bosutinib—STK10—cerebellum—alcohol dependence	0.000231	0.000567	CbGeAlD
Bosutinib—PDGFRB—midbrain—alcohol dependence	0.000231	0.000567	CbGeAlD
Bosutinib—IRAK1—brain—alcohol dependence	0.000231	0.000567	CbGeAlD
Bosutinib—TAOK3—cerebellum—alcohol dependence	0.00023	0.000565	CbGeAlD
Bosutinib—SRC—liver—alcohol dependence	0.00023	0.000564	CbGeAlD
Bosutinib—SRC—central nervous system—alcohol dependence	0.00023	0.000564	CbGeAlD
Bosutinib—CSF1R—endocrine gland—alcohol dependence	0.000229	0.000561	CbGeAlD
Bosutinib—RPS6KB1—brain—alcohol dependence	0.000227	0.000556	CbGeAlD
Bosutinib—FGR—brain—alcohol dependence	0.000225	0.000553	CbGeAlD
Bosutinib—SRC—cerebellum—alcohol dependence	0.000225	0.000551	CbGeAlD
Bosutinib—AXL—brain—alcohol dependence	0.000224	0.000551	CbGeAlD
Bosutinib—MAP2K5—testis—alcohol dependence	0.000224	0.000549	CbGeAlD
Bosutinib—MAP2K5—nervous system—alcohol dependence	0.000219	0.000538	CbGeAlD
Bosutinib—ABL1—digestive system—alcohol dependence	0.000219	0.000537	CbGeAlD
Bosutinib—CSF1R—testis—alcohol dependence	0.000218	0.000535	CbGeAlD
Bosutinib—SLK—brain—alcohol dependence	0.000216	0.00053	CbGeAlD
Bosutinib—EPHB4—brain—alcohol dependence	0.000214	0.000526	CbGeAlD
Bosutinib—CSF1R—nervous system—alcohol dependence	0.000214	0.000525	CbGeAlD
Bosutinib—MAP2K5—liver—alcohol dependence	0.000211	0.000519	CbGeAlD
Bosutinib—MAP2K5—central nervous system—alcohol dependence	0.000211	0.000518	CbGeAlD
Bosutinib—EPHA2—brain—alcohol dependence	0.00021	0.000516	CbGeAlD
Bosutinib—FYN—brain—alcohol dependence	0.00021	0.000515	CbGeAlD
Bosutinib—ABL1—blood—alcohol dependence	0.000209	0.000512	CbGeAlD
Bosutinib—MAP2K5—cerebellum—alcohol dependence	0.000207	0.000507	CbGeAlD
Bosutinib—CSF1R—liver—alcohol dependence	0.000206	0.000506	CbGeAlD
Bosutinib—CSF1R—central nervous system—alcohol dependence	0.000206	0.000506	CbGeAlD
Bosutinib—ABL1—midbrain—alcohol dependence	0.000206	0.000505	CbGeAlD
Bosutinib—MAP4K5—brain—alcohol dependence	0.000205	0.000504	CbGeAlD
Bosutinib—MAP3K3—brain—alcohol dependence	0.000205	0.000504	CbGeAlD
Bosutinib—PDGFRB—endocrine gland—alcohol dependence	0.000203	0.000498	CbGeAlD
Bosutinib—CSF1R—cerebellum—alcohol dependence	0.000202	0.000494	CbGeAlD
Bosutinib—PDGFRB—testis—alcohol dependence	0.000194	0.000475	CbGeAlD
Bosutinib—PDGFRB—nervous system—alcohol dependence	0.00019	0.000466	CbGeAlD
Bosutinib—YES1—brain—alcohol dependence	0.00019	0.000465	CbGeAlD
Bosutinib—STK10—brain—alcohol dependence	0.000188	0.000461	CbGeAlD
Bosutinib—TAOK3—brain—alcohol dependence	0.000187	0.000459	CbGeAlD
Bosutinib—PDGFRB—liver—alcohol dependence	0.000183	0.000449	CbGeAlD
Bosutinib—PDGFRB—central nervous system—alcohol dependence	0.000183	0.000449	CbGeAlD
Bosutinib—SRC—brain—alcohol dependence	0.000182	0.000447	CbGeAlD
Bosutinib—ABL1—endocrine gland—alcohol dependence	0.000181	0.000444	CbGeAlD
Bosutinib—PDGFRB—cerebellum—alcohol dependence	0.000179	0.000439	CbGeAlD
Bosutinib—ABL1—testis—alcohol dependence	0.000173	0.000423	CbGeAlD
Bosutinib—ABL1—nervous system—alcohol dependence	0.000169	0.000415	CbGeAlD
Bosutinib—MAP2K5—brain—alcohol dependence	0.000168	0.000412	CbGeAlD
Bosutinib—CSF1R—brain—alcohol dependence	0.000164	0.000402	CbGeAlD
Bosutinib—ABL1—liver—alcohol dependence	0.000163	0.0004	CbGeAlD
Bosutinib—ABL1—central nervous system—alcohol dependence	0.000163	0.0004	CbGeAlD
Bosutinib—ABL1—cerebellum—alcohol dependence	0.000159	0.000391	CbGeAlD
Bosutinib—PDGFRB—brain—alcohol dependence	0.000145	0.000356	CbGeAlD
Bosutinib—ABL1—brain—alcohol dependence	0.000129	0.000317	CbGeAlD
Bosutinib—ABCB1—forebrain—alcohol dependence	9.7e-05	0.000238	CbGeAlD
Bosutinib—CYP3A4—digestive system—alcohol dependence	9.62e-05	0.000236	CbGeAlD
Bosutinib—CYP3A4—blood—alcohol dependence	9.16e-05	0.000225	CbGeAlD
Bosutinib—ABCB1—adrenal cortex—alcohol dependence	8.99e-05	0.00022	CbGeAlD
Bosutinib—ABCB1—cardiovascular system—alcohol dependence	8.2e-05	0.000201	CbGeAlD
Bosutinib—ABCB1—pancreas—alcohol dependence	7.97e-05	0.000196	CbGeAlD
Bosutinib—CYP3A4—endocrine gland—alcohol dependence	7.95e-05	0.000195	CbGeAlD
Bosutinib—ABCB1—gonad—alcohol dependence	7.44e-05	0.000183	CbGeAlD
Bosutinib—CYP3A4—nervous system—alcohol dependence	7.44e-05	0.000182	CbGeAlD
Bosutinib—CYP3A4—liver—alcohol dependence	7.16e-05	0.000176	CbGeAlD
Bosutinib—CYP3A4—central nervous system—alcohol dependence	7.16e-05	0.000176	CbGeAlD
Bosutinib—ABCB1—digestive system—alcohol dependence	6.81e-05	0.000167	CbGeAlD
Bosutinib—ABCB1—blood—alcohol dependence	6.49e-05	0.000159	CbGeAlD
Bosutinib—ABCB1—midbrain—alcohol dependence	6.4e-05	0.000157	CbGeAlD
Bosutinib—ABCB1—endocrine gland—alcohol dependence	5.63e-05	0.000138	CbGeAlD
Bosutinib—ABCB1—testis—alcohol dependence	5.36e-05	0.000132	CbGeAlD
Bosutinib—ABCB1—nervous system—alcohol dependence	5.26e-05	0.000129	CbGeAlD
Bosutinib—ABCB1—liver—alcohol dependence	5.07e-05	0.000124	CbGeAlD
Bosutinib—ABCB1—central nervous system—alcohol dependence	5.07e-05	0.000124	CbGeAlD
Bosutinib—ABCB1—cerebellum—alcohol dependence	4.95e-05	0.000122	CbGeAlD
Bosutinib—ABCB1—brain—alcohol dependence	4.02e-05	9.87e-05	CbGeAlD
Bosutinib—PDGFRB—Signaling Pathways—NPY—alcohol dependence	2.52e-05	9.68e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—GOT2—alcohol dependence	2.52e-05	9.67e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AVP—alcohol dependence	2.49e-05	9.57e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—DRD4—alcohol dependence	2.49e-05	9.57e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR1B—alcohol dependence	2.49e-05	9.57e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CRH—alcohol dependence	2.49e-05	9.57e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CHRM2—alcohol dependence	2.48e-05	9.54e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADH4—alcohol dependence	2.47e-05	9.5e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NPY—alcohol dependence	2.47e-05	9.47e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR7—alcohol dependence	2.46e-05	9.47e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—DRD2—alcohol dependence	2.46e-05	9.47e-05	CbGpPWpGaD
Bosutinib—CSK—Disease—EP300—alcohol dependence	2.46e-05	9.45e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—EP300—alcohol dependence	2.45e-05	9.39e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—WASF1—alcohol dependence	2.44e-05	9.37e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CRH—alcohol dependence	2.43e-05	9.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR1B—alcohol dependence	2.43e-05	9.33e-05	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—EP300—alcohol dependence	2.43e-05	9.33e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NPY—alcohol dependence	2.43e-05	9.33e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PDYN—alcohol dependence	2.42e-05	9.31e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NPY—alcohol dependence	2.41e-05	9.28e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—HTR2A—alcohol dependence	2.4e-05	9.23e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CHRM2—alcohol dependence	2.39e-05	9.19e-05	CbGpPWpGaD
Bosutinib—TBK1—Immune System—EP300—alcohol dependence	2.39e-05	9.18e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR1B—alcohol dependence	2.38e-05	9.14e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CRH—alcohol dependence	2.38e-05	9.14e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CNR1—alcohol dependence	2.38e-05	9.14e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—HTR2A—alcohol dependence	2.35e-05	9.03e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AVP—alcohol dependence	2.35e-05	9.02e-05	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—EP300—alcohol dependence	2.35e-05	9.01e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR1B—alcohol dependence	2.34e-05	9e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CRH—alcohol dependence	2.34e-05	9e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CRH—alcohol dependence	2.33e-05	8.95e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR1B—alcohol dependence	2.33e-05	8.95e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR7—alcohol dependence	2.32e-05	8.91e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—DRD2—alcohol dependence	2.32e-05	8.91e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—HTR2A—alcohol dependence	2.32e-05	8.9e-05	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—EP300—alcohol dependence	2.29e-05	8.8e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—EP300—alcohol dependence	2.29e-05	8.78e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—OPRM1—alcohol dependence	2.28e-05	8.75e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—EP300—alcohol dependence	2.26e-05	8.69e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—GOT1—alcohol dependence	2.26e-05	8.67e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WASF2—alcohol dependence	2.25e-05	8.65e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CRHR1—alcohol dependence	2.25e-05	8.65e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—HTR2A—alcohol dependence	2.25e-05	8.64e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—HTR2A—alcohol dependence	2.23e-05	8.57e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—GOT2—alcohol dependence	2.23e-05	8.56e-05	CbGpPWpGaD
Bosutinib—BTK—Immune System—EP300—alcohol dependence	2.23e-05	8.56e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AVP—alcohol dependence	2.22e-05	8.52e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—OPRM1—alcohol dependence	2.2e-05	8.44e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AVP—alcohol dependence	2.19e-05	8.4e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DRD4—alcohol dependence	2.18e-05	8.36e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—GOT1—alcohol dependence	2.17e-05	8.35e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—POMC—alcohol dependence	2.17e-05	8.35e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADH6—alcohol dependence	2.16e-05	8.31e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—EP300—alcohol dependence	2.16e-05	8.3e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.16e-05	8.3e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WASF1—alcohol dependence	2.16e-05	8.3e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—EP300—alcohol dependence	2.15e-05	8.26e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—HTR2A—alcohol dependence	2.15e-05	8.26e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—HTR2A—alcohol dependence	2.15e-05	8.26e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—EP300—alcohol dependence	2.14e-05	8.21e-05	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—EP300—alcohol dependence	2.13e-05	8.18e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—EP300—alcohol dependence	2.13e-05	8.17e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DRD4—alcohol dependence	2.12e-05	8.16e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—EP300—alcohol dependence	2.12e-05	8.14e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CHRM2—alcohol dependence	2.12e-05	8.14e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—EP300—alcohol dependence	2.12e-05	8.13e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—EP300—alcohol dependence	2.11e-05	8.11e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADH7—alcohol dependence	2.1e-05	8.08e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NPY—alcohol dependence	2.1e-05	8.06e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—EP300—alcohol dependence	2.09e-05	8.02e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD4—alcohol dependence	2.08e-05	7.99e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CNR1—alcohol dependence	2.08e-05	7.98e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AVP—alcohol dependence	2.07e-05	7.97e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—HTR2A—alcohol dependence	2.07e-05	7.96e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—EP300—alcohol dependence	2.06e-05	7.91e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD4—alcohol dependence	2.05e-05	7.86e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—EP300—alcohol dependence	2.05e-05	7.86e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD4—alcohol dependence	2.04e-05	7.82e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CNR1—alcohol dependence	2.03e-05	7.79e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—DRD2—alcohol dependence	2.03e-05	7.79e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR7—alcohol dependence	2.03e-05	7.79e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR1B—alcohol dependence	2.02e-05	7.77e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CRH—alcohol dependence	2.02e-05	7.77e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NPY—alcohol dependence	2.02e-05	7.76e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGT2—alcohol dependence	2.02e-05	7.74e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Biological oxidations—POMC—alcohol dependence	2e-05	7.7e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—EP300—alcohol dependence	2e-05	7.67e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CNR1—alcohol dependence	1.99e-05	7.63e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	1.98e-05	7.62e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—DRD2—alcohol dependence	1.98e-05	7.6e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR7—alcohol dependence	1.98e-05	7.6e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CNR1—alcohol dependence	1.95e-05	7.51e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—HTR2A—alcohol dependence	1.95e-05	7.5e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AVP—alcohol dependence	1.95e-05	7.5e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR1B—alcohol dependence	1.95e-05	7.49e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CRH—alcohol dependence	1.95e-05	7.49e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—EP300—alcohol dependence	1.95e-05	7.49e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CNR1—alcohol dependence	1.94e-05	7.47e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—OPRM1—alcohol dependence	1.94e-05	7.47e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR7—alcohol dependence	1.94e-05	7.44e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—DRD2—alcohol dependence	1.94e-05	7.44e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—EP300—alcohol dependence	1.93e-05	7.4e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—GOT1—alcohol dependence	1.92e-05	7.39e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—POMC—alcohol dependence	1.92e-05	7.38e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—EP300—alcohol dependence	1.91e-05	7.33e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR7—alcohol dependence	1.91e-05	7.33e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—DRD2—alcohol dependence	1.91e-05	7.33e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—EP300—alcohol dependence	1.9e-05	7.3e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—EP300—alcohol dependence	1.9e-05	7.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—DRD2—alcohol dependence	1.9e-05	7.29e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR7—alcohol dependence	1.9e-05	7.29e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—EP300—alcohol dependence	1.89e-05	7.25e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—EP300—alcohol dependence	1.88e-05	7.22e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—POMC—alcohol dependence	1.88e-05	7.21e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—EP300—alcohol dependence	1.87e-05	7.18e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—EP300—alcohol dependence	1.85e-05	7.12e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—POMC—alcohol dependence	1.85e-05	7.11e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—EP300—alcohol dependence	1.85e-05	7.1e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—HTR2A—alcohol dependence	1.84e-05	7.09e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADH1B—alcohol dependence	1.84e-05	7.08e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—EP300—alcohol dependence	1.84e-05	7.06e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—HTR2A—alcohol dependence	1.82e-05	6.99e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—EP300—alcohol dependence	1.82e-05	6.98e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—POMC—alcohol dependence	1.8e-05	6.9e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.79e-05	6.88e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NPY—alcohol dependence	1.79e-05	6.87e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.79e-05	6.87e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—EP300—alcohol dependence	1.78e-05	6.85e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—EP300—alcohol dependence	1.78e-05	6.85e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—POMC—alcohol dependence	1.78e-05	6.85e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—EP300—alcohol dependence	1.78e-05	6.83e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD4—alcohol dependence	1.77e-05	6.79e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—EP300—alcohol dependence	1.74e-05	6.68e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR1B—alcohol dependence	1.73e-05	6.63e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CRH—alcohol dependence	1.73e-05	6.63e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—HTR2A—alcohol dependence	1.73e-05	6.63e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—EP300—alcohol dependence	1.72e-05	6.62e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—POMC—alcohol dependence	1.72e-05	6.6e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—POMC—alcohol dependence	1.72e-05	6.6e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AVP—alcohol dependence	1.71e-05	6.56e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD4—alcohol dependence	1.7e-05	6.55e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—EP300—alcohol dependence	1.7e-05	6.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CNR1—alcohol dependence	1.69e-05	6.49e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AVP—alcohol dependence	1.67e-05	6.4e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—POMC—alcohol dependence	1.66e-05	6.36e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR7—alcohol dependence	1.65e-05	6.33e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—DRD2—alcohol dependence	1.65e-05	6.33e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AVP—alcohol dependence	1.63e-05	6.26e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CNR1—alcohol dependence	1.63e-05	6.25e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—HTR2A—alcohol dependence	1.62e-05	6.24e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—EP300—alcohol dependence	1.62e-05	6.24e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AVP—alcohol dependence	1.61e-05	6.17e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AVP—alcohol dependence	1.6e-05	6.13e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—DRD2—alcohol dependence	1.59e-05	6.1e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR7—alcohol dependence	1.59e-05	6.1e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—EP300—alcohol dependence	1.57e-05	6.02e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—EP300—alcohol dependence	1.57e-05	6.02e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—EP300—alcohol dependence	1.56e-05	6.01e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—POMC—alcohol dependence	1.56e-05	5.99e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—EP300—alcohol dependence	1.54e-05	5.91e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOB—alcohol dependence	1.53e-05	5.87e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADH4—alcohol dependence	1.52e-05	5.85e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—EP300—alcohol dependence	1.51e-05	5.81e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD4—alcohol dependence	1.51e-05	5.8e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—EP300—alcohol dependence	1.49e-05	5.73e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—POMC—alcohol dependence	1.47e-05	5.66e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—POMC—alcohol dependence	1.45e-05	5.58e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—EP300—alcohol dependence	1.44e-05	5.54e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CNR1—alcohol dependence	1.44e-05	5.53e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—HTR2A—alcohol dependence	1.42e-05	5.46e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—EP300—alcohol dependence	1.41e-05	5.43e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—DRD2—alcohol dependence	1.41e-05	5.4e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR7—alcohol dependence	1.41e-05	5.4e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AVP—alcohol dependence	1.39e-05	5.33e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—HTR2A—alcohol dependence	1.39e-05	5.32e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—EP300—alcohol dependence	1.38e-05	5.32e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—POMC—alcohol dependence	1.38e-05	5.29e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—HTR2A—alcohol dependence	1.36e-05	5.21e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AVP—alcohol dependence	1.34e-05	5.13e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—HTR2A—alcohol dependence	1.34e-05	5.13e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—EP300—alcohol dependence	1.33e-05	5.12e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—HTR2A—alcohol dependence	1.33e-05	5.1e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALDH2—alcohol dependence	1.3e-05	4.99e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—POMC—alcohol dependence	1.3e-05	4.99e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADH7—alcohol dependence	1.3e-05	4.98e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—EP300—alcohol dependence	1.25e-05	4.79e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT2—alcohol dependence	1.24e-05	4.77e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—EP300—alcohol dependence	1.23e-05	4.72e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AVP—alcohol dependence	1.18e-05	4.55e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—EP300—alcohol dependence	1.18e-05	4.54e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—EP300—alcohol dependence	1.16e-05	4.47e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—HTR2A—alcohol dependence	1.15e-05	4.43e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—EP300—alcohol dependence	1.14e-05	4.38e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—EP300—alcohol dependence	1.14e-05	4.38e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.14e-05	4.36e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—EP300—alcohol dependence	1.14e-05	4.36e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—POMC—alcohol dependence	1.13e-05	4.36e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—HTR2A—alcohol dependence	1.11e-05	4.27e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—EP300—alcohol dependence	1.11e-05	4.27e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—POMC—alcohol dependence	1.11e-05	4.25e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EP300—alcohol dependence	1.11e-05	4.25e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT2—alcohol dependence	1.1e-05	4.24e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EP300—alcohol dependence	1.1e-05	4.22e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—EP300—alcohol dependence	1.09e-05	4.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EP300—alcohol dependence	1.09e-05	4.18e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—POMC—alcohol dependence	1.08e-05	4.16e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EP300—alcohol dependence	1.07e-05	4.13e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—alcohol dependence	1.07e-05	4.1e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—alcohol dependence	1.06e-05	4.08e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EP300—alcohol dependence	1.05e-05	4.03e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.04e-05	3.99e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—EP300—alcohol dependence	1.01e-05	3.88e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EP300—alcohol dependence	1.01e-05	3.86e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—alcohol dependence	9.84e-06	3.78e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EP300—alcohol dependence	9.77e-06	3.76e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EP300—alcohol dependence	9.64e-06	3.7e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GGT1—alcohol dependence	9.53e-06	3.66e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GOT1—alcohol dependence	9.53e-06	3.66e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—EP300—alcohol dependence	9.46e-06	3.63e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOB—alcohol dependence	9.41e-06	3.62e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—alcohol dependence	9.22e-06	3.54e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EP300—alcohol dependence	9.14e-06	3.51e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—EP300—alcohol dependence	9.11e-06	3.5e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—alcohol dependence	8.88e-06	3.41e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—EP300—alcohol dependence	8.73e-06	3.35e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EP300—alcohol dependence	8.61e-06	3.31e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—MAOA—alcohol dependence	8.54e-06	3.28e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—EP300—alcohol dependence	8.41e-06	3.23e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—EP300—alcohol dependence	8.07e-06	3.1e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALDH2—alcohol dependence	8e-06	3.07e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—alcohol dependence	7.86e-06	3.02e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EP300—alcohol dependence	7.52e-06	2.89e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—EP300—alcohol dependence	7.45e-06	2.86e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EP300—alcohol dependence	7.34e-06	2.82e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EP300—alcohol dependence	7.19e-06	2.76e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EP300—alcohol dependence	7.08e-06	2.72e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EP300—alcohol dependence	7.04e-06	2.7e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT2—alcohol dependence	6.81e-06	2.61e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.4e-06	2.46e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EP300—alcohol dependence	6.11e-06	2.35e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EP300—alcohol dependence	5.89e-06	2.26e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GGT1—alcohol dependence	5.87e-06	2.26e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GOT1—alcohol dependence	5.87e-06	2.26e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—alcohol dependence	5.56e-06	2.14e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—MAOA—alcohol dependence	5.26e-06	2.02e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EP300—alcohol dependence	5.22e-06	2e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—EP300—alcohol dependence	3.69e-06	1.42e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—alcohol dependence	3.43e-06	1.32e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—EP300—alcohol dependence	2.27e-06	8.73e-06	CbGpPWpGaD
